Enter Symbol click to research


Blog Articles for MYL
Rich Bieglmeier image
Mylan, Inc. (MYL) Q3 Earnings Preview: Weak Dollar = Strong Profit?
By: Rich Bieglmeier
Publish Date: Wednesday, October 30, 2013
Stocks(s): , MYL
Sector(s): Medical

Michael Vodicka image
Mylan Inc (MYL): Patent Cliff Set To Fuel 200% Gain
By: Michael Vodicka
Publish Date: Monday, August 12, 2013
Stocks(s): ACT, MRK, MYL, PFE, RDY
Sector(s): Medical

Balachander image
Futures Rise After Payrolls Data; LinkedIn (LNKD) Drops
By: Balachander
Publish Date: Friday, May 3, 2013
Stocks(s): AIG, ARNA, FLT, LNKD, MYL, REGN, TDC, VCRA
Sector(s): Finance, Computer and Technology, Medical

TheStockAdvisors.com image
Pharma Favorites With Buybacks
By: TheStockAdvisors.com
Publish Date: Monday, April 22, 2013
Stocks(s): MYL, UTHR
Sector(s): Medical

Mani image
Valeant Pharmaceuticals Intl Inc: Mylan's Unexpected Zovirax Generic Dampens 2013 EPS View
By: Mani
Publish Date: Thursday, April 4, 2013
Stocks(s): , MYL, VRX
Sector(s): Medical

Covestor.com image
Generic Drugmaker Mylan Is A Smart Healthcare Play
By: Covestor.com
Publish Date: Thursday, March 21, 2013
Stocks(s): ACA, BIIB, CELG, IDXX, LLY, MCK, MDT, MWIV
Sector(s): Finance, Medical, Business Services

Orange Book Blog image
"Defective" Complaint Triggers 30-Month Stay
By: Orange Book Blog
Publish Date: Thursday, March 14, 2013
Stocks(s): ENDP, MYL
Sector(s): Medical

Balaseshan image
Mylan (MYL) Launches Generic Version Of Merck's (MRK) Migraine Drug
By: Balaseshan
Publish Date: Wednesday, January 2, 2013
Stocks(s): MRK, MYL
Sector(s): Medical

Covestor.com image
Healthcare Poised For Growth Under Obamacare
By: Covestor.com
Publish Date: Wednesday, January 2, 2013
Stocks(s): AMGN, BAX, CELG, ESRX, JNJ, MWIV, MYL, NVO
Sector(s): Medical

Balaseshan image
AstraZeneca (AZN) Receives Favorable Patent Appeal Ruling For Cholesterol Drug Crestor
By: Balaseshan
Publish Date: Friday, December 14, 2012
Stocks(s): AZN, MYL, PRX, TEVA
Sector(s): Medical, Europe

Balachander image
Analysts' Rating And Target Changes: DELL, GPS, JBLU, MYL, NTAP, WMT
By: Balachander
Publish Date: Friday, November 16, 2012
Stocks(s): DELL, GPS, GS, JBLU, MYL, NTAP, WMT
Sector(s): Finance, Computer and Technology, Retail/Wholesale

Balaseshan image
Mylan (MYL) Launches Generic Version Of Pfizer's (PFE) Pulmonary Hypertension Drug
By: Balaseshan
Publish Date: Tuesday, November 13, 2012
Stocks(s): MYL, PFE
Sector(s): Medical

Covestor.com image
Teva Pharmaceutical Is An Attractive Buying Opportunity
By: Covestor.com
Publish Date: Monday, November 5, 2012
Stocks(s): CNS, DNA, MYL, NOVN, TEVA
Sector(s): Medical

Balaseshan image
Mylan (MYL) 3Q Earnings Jump 42 Pct, Beat Estimates; Lifts 2012 Profit View
By: Balaseshan
Publish Date: Thursday, October 25, 2012
Stocks(s): MYL
Sector(s): Medical

Balachander image
Mylan (MYL) Files Expedited Motion Related to Generic Diabetes Drug
By: Balachander
Publish Date: Tuesday, October 23, 2012
Stocks(s): MYL, WPI
Sector(s): Medical

Balachander image
Endo Health (ENDP) Downgraded To 'Sector Perform' By RBC Capital, PT Lowered
By: Balachander
Publish Date: Friday, October 5, 2012
Stocks(s): ENDP, MYL
Sector(s): Medical

StreetAuthority image
Obama Or Romney? How To Invest Based On The November Election
By: StreetAuthority
Publish Date: Wednesday, October 3, 2012
Stocks(s): BA, BAC, BPL, BWP, C, CE, COP, CPSI
Sector(s): Finance, Basic Materials, Utilities

Balaseshan image
Mylan (MYL) Launches Generic Of Pfizer's (PFE) Motion Sickness Drug
By: Balaseshan
Publish Date: Friday, September 21, 2012
Stocks(s): MYL, PFE
Sector(s): Medical

Balachander image
FDA Clears Generic Version Takeda's Type 2 Diabetes Drug Actos
By: Balachander
Publish Date: Friday, August 17, 2012
Stocks(s): MYL, TEVA, WPI
Sector(s): Medical

Balaseshan image
Mylan (MYL) Launches Generic Of Hospira's (HSP) General Anesthesia Induction Therapy
By: Balaseshan
Publish Date: Monday, August 6, 2012
Stocks(s): HSP, MYL, PFE
Sector(s): Medical

Balaseshan image
Mylan (MYL) To Make Generic Gilead's (GILD) HIV/AIDS Therapies Containing Emtricitabine
By: Balaseshan
Publish Date: Thursday, August 2, 2012
Stocks(s): GILD, MYL
Sector(s): Medical

Balaseshan image
Mylan (MYL) Launches Generic Version Of Anti-Fungal Drug Sporanox
By: Balaseshan
Publish Date: Friday, July 27, 2012
Stocks(s): MYL
Sector(s): Medical

Balaseshan image
Mylan (MYL) Posts Stronger-Than-Expected Q2
By: Balaseshan
Publish Date: Thursday, July 26, 2012
Stocks(s): MYL
Sector(s): Medical

Balaseshan image
Teva (TEVA) Gets Positive Copaxone Patent Ruling From U.K. Court
By: Balaseshan
Publish Date: Wednesday, July 11, 2012
Stocks(s): MYL, TEVA
Sector(s): Medical, Europe

Balaseshan image
Mylan (MYL) Gets Approval For Generic Pulmonary Arterial Hypertension Drug
By: Balaseshan
Publish Date: Wednesday, June 6, 2012
Stocks(s): MYL
Sector(s): Medical

PreviousPage 1 of 5Next
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.